Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) Gross Profit (2016 - 2025)

Historic Gross Profit for Biomerica (BMRA) over the last 16 years, with Q4 2025 value amounting to $51000.0.

  • Biomerica's Gross Profit fell 8832.95% to $51000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $250000.0, marking a year-over-year decrease of 5812.4%. This contributed to the annual value of $498000.0 for FY2025, which is 1849.43% down from last year.
  • Per Biomerica's latest filing, its Gross Profit stood at $51000.0 for Q4 2025, which was down 8832.95% from $424000.0 recorded in Q3 2025.
  • Over the past 5 years, Biomerica's Gross Profit peaked at $1.7 million during Q1 2022, and registered a low of -$244000.0 during Q2 2025.
  • In the last 5 years, Biomerica's Gross Profit had a median value of $85500.0 in 2023 and averaged $247323.8.
  • As far as peak fluctuations go, Biomerica's Gross Profit skyrocketed by 471086.92% in 2022, and later plummeted by 132000.0% in 2025.
  • Quarter analysis of 5 years shows Biomerica's Gross Profit stood at $771759.0 in 2021, then crashed by 54.39% to $352000.0 in 2022, then decreased by 7.67% to $325000.0 in 2023, then surged by 34.46% to $437000.0 in 2024, then plummeted by 88.33% to $51000.0 in 2025.
  • Its Gross Profit was $51000.0 in Q4 2025, compared to $424000.0 in Q3 2025 and -$244000.0 in Q2 2025.